|
|
|
| 
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
|
Genmark Diagnostics, Inc. (GNMK) |
|
|
$24.04 0.00 (0.00%) as of 4:30 Tue 4/20
|
|
Download |
|
|
| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
71,720,000 |
| Market
Cap: |
1.72(B) |
| Last
Volume: |
8,115 |
Avg
Vol: |
8,092 |
| 52
Week Range: |
$24.04 - $24.04 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Health Services |
| Level
III Sector: |
Medical Appliances & Equipment |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-18 |
2023-10-17 |
2023-04-18 |
2022-04-18 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Obrien Scott Alexander |
SVP, Global Mktg & Intl Sales |
• – – |
2021-04-22 |
4 |
D |
$24.05 |
$4,109,640 |
D/D |
(170,879) |
0 |
|
- |
|
| Harkins Michael John |
SVP, Sales |
• – – |
2021-04-22 |
4 |
D |
$24.05 |
$3,468,347 |
D/D |
(144,214) |
0 |
|
- |
|
| Mendel Scott |
President & CEO |
• • – |
2021-04-22 |
4 |
D |
$24.05 |
$2,777,559 |
I/I |
(115,491) |
0 |
|
- |
|
| Mendel Scott |
President & CEO |
• • – |
2021-04-22 |
4 |
D |
$24.05 |
$12,198,112 |
D/D |
(507,198) |
0 |
|
- |
|
| Chohan Abdul |
SVP Operations |
• – – |
2021-04-22 |
4 |
D |
$24.05 |
$1,533,188 |
D/D |
(63,750) |
0 |
|
- |
|
| Jensen Tyler |
SVP, Engineering and Tech Dev |
• – – |
2021-04-22 |
4 |
D |
$24.05 |
$5,104,588 |
D/D |
(212,249) |
0 |
|
- |
|
| Winkler Sarah Hollis |
VP, Human Resources |
• – – |
2021-04-22 |
4 |
D |
$24.05 |
$3,547,423 |
D/D |
(147,502) |
0 |
|
- |
|
| Oboyle Kevin C |
Director |
– • – |
2021-04-22 |
4 |
D |
$24.05 |
$3,166,856 |
D/D |
(131,678) |
0 |
|
- |
|
| Faulkner Daryl |
Director |
– • – |
2021-04-22 |
4 |
D |
$24.05 |
$3,219,598 |
D/D |
(133,871) |
0 |
|
- |
|
| Shaw Christine |
VP, Assay Development |
• – – |
2021-04-22 |
4 |
D |
$24.05 |
$2,436,842 |
D/D |
(101,324) |
0 |
|
- |
|
| Ek John Frederick |
Chief Financial Officer |
• – – |
2021-04-22 |
4 |
D |
$24.05 |
$5,603,482 |
D/D |
(232,993) |
0 |
|
- |
|
| Kagnoff Michael |
Director |
– • – |
2021-04-22 |
4 |
D |
$24.05 |
$3,302,522 |
D/D |
(137,319) |
0 |
|
- |
|
| Stevenson Wade R. |
SVP, North America Sales |
• – – |
2021-04-22 |
4 |
D |
$24.05 |
$1,202,500 |
D/D |
(50,000) |
0 |
|
- |
|
| Gleeson Michael |
SVP, Corp. Accounts |
• – – |
2021-04-22 |
4 |
D |
$24.05 |
$723,159 |
I/I |
(30,069) |
0 |
|
- |
|
| Gleeson Michael |
SVP, Corp. Accounts |
• – – |
2021-04-22 |
4 |
D |
$24.05 |
$10,134,261 |
D/D |
(421,383) |
0 |
|
- |
|
| Maderazo Alan Baer |
VP, Qual, Reg, & Clin Affairs |
• – – |
2021-04-22 |
4 |
D |
$24.05 |
$6,305,429 |
D/D |
(262,180) |
0 |
|
- |
|
| Fox James |
Director |
– • – |
2021-04-22 |
4 |
D |
$24.05 |
$1,950,094 |
I/I |
(81,085) |
0 |
|
- |
|
| Fox James |
Director |
– • – |
2021-04-22 |
4 |
D |
$24.05 |
$4,377,509 |
D/D |
(182,017) |
0 |
|
- |
|
| Giles Lisa M. |
Director |
– • – |
2021-04-22 |
4 |
D |
$24.05 |
$132,275 |
I/I |
(5,500) |
0 |
|
- |
|
| Giles Lisa M. |
Director |
– • – |
2021-04-22 |
4 |
D |
$24.05 |
$1,961,807 |
D/D |
(81,572) |
0 |
|
- |
|
| Stier Eric |
SVP & General Counsel |
• – – |
2021-04-22 |
4 |
D |
$24.05 |
$6,637,175 |
D/D |
(275,974) |
0 |
|
- |
|
| Gleeson Michael |
SVP, Corp. Accounts |
• – – |
2021-04-14 |
4 |
OE |
$10.89 |
$326,560 |
D/D |
27,667 |
420,410 |
|
- |
|
| Stevenson Wade R. |
SVP, North America Sales |
• – – |
2021-04-09 |
4 |
A |
$0.00 |
$0 |
D/D |
50,000 |
50,000 |
|
- |
|
| Shaw Christine |
VP, Assay Development |
• – – |
2021-04-01 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,730) |
100,466 |
|
- |
|
| Jensen Tyler |
SVP, Engineering and Tech Dev |
• – – |
2021-03-18 |
4 |
AS |
$23.88 |
$11,940 |
D/D |
(500) |
211,888 |
|
1% |
|
1023 Records found
|
|
Page 1 of 41 |
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
| |
OE |
- Options Exercised |
A |
- Acquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
